Trial Profile
A study of the effectiveness and tolerability of duloxetine (Cymbalta) in the treatment of PTSD [posttraumatic stress disorder]
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 27 Feb 2017
Price :
$35
*
At a glance
- Drugs Duloxetine (Primary)
- Indications Post-traumatic stress disorders
- Focus Therapeutic Use
- 22 Jan 2008 New trial record.